Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
03.01.24 | IRLAB Therapeutics - End-of-Phase II FDA meeting set | 493 | Edison Investment Research | IRLAB Therapeutics has scheduled an end-of-Phase II (EoP2) meeting (on 20 February 2024) with the US FDA for the mesdopetam programme. This marks an important milestone for IRLAB as it will evaluate... ► Artikel lesen | |
03.01.24 | Sequana Medical - PMA application submitted to FDA for alfapump | 367 | Edison Investment Research | Sequana Medical announced in late December that it has submitted a Premarket Approval (PMA) application to the US FDA regarding its alfapump device for use in patients with recurrent and refractory... ► Artikel lesen | |
03.01.24 | Sareum Holdings - SRA737 - new partnership to kick off the year | 410 | Edison Investment Research | Sareum Holdings' co-development partner CRT Pioneer Fund (CPF) has signed a new licensing agreement with an unnamed US-based private biopharma company for SRA737, its Phase II stage CHK1 inhibitor targeting... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
TESLA | 2.891 |
NVIDIA | 2.770 |
THYSSENKRUPP | 2.348 |
RENK GROUP | 2.160 |
STEYR MOTORS | 1.942 |
DEUTZ | 1.907 |
BYD | 1.831 |
NEL | 1.809 |
RHEINMETALL | 1.756 |
BAYER | 1.622 |
XIAOMI | 1.461 |
TUI | 1.459 |
NOVO NORDISK | 1.280 |
EVOTEC | 1.166 |
COMMERZBANK | 967 |
VOLKSWAGEN | 867 |
DEUTSCHE BANK | 858 |
MUTARES | 838 |
AIXTRON SE | 808 |
MERCEDES-BENZ | 790 |
NORDEX | 774 |
BASF | 723 |
PORSCHE AG | 717 |
PUMA | 684 |
RWE | 671 |